These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2759015

  • 1. [Phosphorus-containing metabolites in the cells of anthracycline-resistant strains of leukemia P388].
    Shiriaeva OA, Semenova NA, Sibel'dina LA, Goncharova SA, Konovalova NP.
    Eksp Onkol; 1989; 11(4):70-3. PubMed ID: 2759015
    [Abstract] [Full Text] [Related]

  • 2. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells.
    Shiryaeva OA, Semenova NA, Sibeldina LA, Goncharova SA, Konovalova NP.
    Neoplasma; 1992; 39(4):229-32. PubMed ID: 1436233
    [Abstract] [Full Text] [Related]

  • 3. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
    Demidova NS, Goncharova SA, Shiriaeva OA, Konovalova NP.
    Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
    [Abstract] [Full Text] [Related]

  • 4. [Characteristics of anthracycline-resistant strains of P388 leukemia].
    Goncharova SA, Demidova NS, Shiriaeva OA, Shevtsova VN, Konovalova NP.
    Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
    [Abstract] [Full Text] [Related]

  • 5. [Role of intracellular pH in the development of resistance of leukemic cells to antineoplastic drugs].
    Shestova OL, Ogloblina TA, Litinskaia LL.
    Eksp Onkol; 1990; 12(3):61-2. PubMed ID: 2344828
    [Abstract] [Full Text] [Related]

  • 6. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D, Wilberding C.
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [Abstract] [Full Text] [Related]

  • 7. [Gene amplification in murine leukemia cells with multiple drug resistance acquired in vivo].
    Demidova NS, Goncharova SA, Chernova OB, Kopnin BP, Gudkov AV.
    Genetika; 1987 Oct; 23(10):1797-806. PubMed ID: 3692152
    [Abstract] [Full Text] [Related]

  • 8. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A, Cohen L, Glaubiger D.
    Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
    [Abstract] [Full Text] [Related]

  • 9. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K, Kojima N, Yamamoto S, Tatsumi K, Mino M, Yagi K.
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [Abstract] [Full Text] [Related]

  • 10. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A, Fuks Z, Gatt S, Glaubiger D.
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [Abstract] [Full Text] [Related]

  • 11. Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells.
    Gessner T, Vaughan LA, Beehler BC, Bartels CJ, Baker RM.
    Cancer Res; 1990 Jul 01; 50(13):3921-7. PubMed ID: 2112982
    [Abstract] [Full Text] [Related]

  • 12. Exploring multidrug resistance using rhodamine 123.
    Kessel D.
    Cancer Commun; 1989 Jul 01; 1(3):145-9. PubMed ID: 2639727
    [Abstract] [Full Text] [Related]

  • 13. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
    Yanovich S, Taub RN.
    Cancer Res; 1983 Sep 01; 43(9):4167-71. PubMed ID: 6871858
    [Abstract] [Full Text] [Related]

  • 14. High calcium content of pleiotropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells.
    Tsuruo T, Iida H, Kawabata H, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Nov 01; 44(11):5095-9. PubMed ID: 6593116
    [Abstract] [Full Text] [Related]

  • 15. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD, Steinkampf RW, Havlick MJ, Jackson RC.
    Cancer Res; 1986 Sep 01; 46(9):4352-6. PubMed ID: 3460695
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN, Ardalan B, Deas M, Johnson RK.
    Cancer Res; 1985 Jan 01; 45(1):207-12. PubMed ID: 2578092
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993 Jan 01; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 18. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ, Wang H, Blair GW.
    Cancer Res; 1986 Jun 01; 46(6):2978-83. PubMed ID: 3698020
    [Abstract] [Full Text] [Related]

  • 19. Kinetic analysis of active efflux of vincristine from multidrug-resistant P388 leukemia cells.
    Inaba M, Watanabe T, Sugiyama Y.
    Jpn J Cancer Res; 1987 Apr 01; 78(4):397-404. PubMed ID: 3108219
    [Abstract] [Full Text] [Related]

  • 20. Anthracycline photoaffinity labeling of a mitochondrial polypeptide in P388 murine leukemic cell lines.
    Averbuch SD, Glover CJ, Felsted RL.
    Cancer Res; 1986 Dec 01; 46(12 Pt 1):6120-4. PubMed ID: 3465435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.